Pharma Reviews: Fosun agrees to buy KKR-backed Indian drugmaker for up to $1.3 billion

Moody's Indian associate ICRA expects patents to expire on about $16 billion ... Gland Pharma's founders and U.S. private equity firm KKR jointly hold ...
Read more: Fosun agrees to buy KKR-backed Indian drugmaker for up to $1.3 billion